BCN Peptides iniciates a collaboration with IDP-Pharma

BCN Peptides supports IDP-Pharma in the development of a new chemical entity aimed to treat Multiple Myeloma.

The collaborative project has been granted with funds from the European Union FEDER via ACCIO and its programme”Nuclis d’Innovació Tecnológica”.